Lots of Ink on HIV-fighting gel after Financial Times (says AAAS) breaks the embargo
Tuesday, July 20th, 2010On Monday the Financial Times‘s Andrew Jack reported from an International AIDS Conference in Vienna that a study – its results supposedly embargoed until today by Science magazine – has found that a vaginal gel tested in Africa appears to reduce HIV infection rates significantly. Jack cites as his sources two people who have been briefed on the results, and did not overtly use anything provided by the journal in advance. He also got philanthropist and Microsoft founder Bill Gates to go on record about making the gel, should tests confirm early results, affordable and available.
So whether or not the reporter technically broke the the embargo’s self-assigned rules, the result is the same. AAAS lifted it. Thus a day early, news is spreading and is getting fairly wide pick up including a tremendous NYTimes splash. Clearly Jack at the FT was not the only reporter gathering additional info ahead of the embargo’s scheduled lift. Further info on the break is at, natch, Ivan Oransky‘s site Embargo Watch.
Does this question make enough sense to ask of the researchers: Is there any chance that already-infected women who use the gel also thereby reduce odds they will pass the virus on to others? Might such a two-way protection be apparent under further testing protocols? Another: epidemiologically, what increment of reduction in transmission rates might be enough to drop the epidemic below what is required to sustain itself? That is, is a one-third to one-half drop enough to put out the fire?
Stories:
- NYTimes – Celia W. Dugger: African Studies Give Women Hope in H.I.V. Fight ; On page 1, top right with a large photo, she ties the Science study on the gel to other evidence that microloans and small grants to girls and their families led to delayed and more careful sex, reducing odd of contracting HIV.
- AP – Marilynn Marchione: AIDS breakthrough: Gel helps prevent infection ; Interesting detail here on what efficacy it would need to get FDA approval vs. the lower threshold that might be enough for use elsewhere. As context, Marchione reports that in South Africa one in three girls is infected with HIV by age 20.
- Agence France-Presse: Anti=HIV gel ‘milestone’ for prevention ;
- CBC (Canada, + AP)): Anti-HIV gel protects women: study ;
- BBC – David Campanale (video link) Vaginal gel ‘slashes HIV risks’ in South African tests ;
- Washington Post – David Brown: Gel found to reduce AIDS risk in women;
- Times (S. Africa) Claire Keeton: Great results for HIV prevention, to be presented at Vienna today ;
- Reuters – Kate Kelland: S. Africa eager to see speedy roll-out of AIDS gel ; reported from Vienna.
- AlJazeera: Gel ‘helps prevent’ HIV infection ; service credits “agencies” in part, but also seems to have gotten direct quotes itself.
- Charlie Petit